Literature DB >> 8039911

Identification of staphylococcal enterotoxin B sequences important for induction of lymphocyte proliferation by using synthetic peptide fragments of the toxin.

M Jett1, R Neill, C Welch, T Boyle, E Bernton, D Hoover, G Lowell, R E Hunt, S Chatterjee, P Gemski.   

Abstract

A series of 13 synthetic peptides, approximately 30 amino acids each, which spanned the entire sequence of staphylococcal enterotoxin B (SEB) were tested to evaluate their effects on T-cell proliferation in a culture system containing elutriated human peripheral blood lymphocytes incubated with a specific ratio of mononuclear cells. Four peptide regions were found to inhibit SEB-induced proliferation; they included sequences 1 to 30 (previously thought to be involved in major histocompatibility complex class II binding), 61 to 92 (sequences which relate to the T-cell receptor site), 93 to 112 (a linear sequence corresponding to the cysteine loop), and 130 to 160 (containing a highly conserved sequence, KKKVTAQEL). Antisera raised to this last peptide were capable of neutralizing SEB-induced proliferation. Antisera raised against the peptides which overlapped this sequence also were somewhat inhibitory. Neutralizing antisera were not produced from any other peptide sequence tested. To determine if any of these effects were nonspecific with regard to SEB-induced proliferation, the peptides were tested for inhibition of phorbol dibutyryl ester-induced proliferation, and only the sequence 93 to 112 (corresponding to the cysteinyl loop region) was consistently inhibitory (40%). Of the regions which displayed inhibition of SEB-induced proliferation, the peptide 130 to 160 inhibited binding of 125I-SEB to lymphocytes. These data suggest that the residues containing and surrounding the sequence KKKVTAQEL may be critical in the SEB-induced proliferation and may be useful for developing neutralizing antisera to SEB.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8039911      PMCID: PMC302972          DOI: 10.1128/iai.62.8.3408-3415.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  PYROGENIC EFFECT OF PURIFIED STAPHYLOCOCCAL ENTEROTOXIN.

Authors:  W G CLARK; H L BORISON
Journal:  J Pharmacol Exp Ther       Date:  1963-11       Impact factor: 4.030

2.  ENHANCEMENT OF BACTERIAL ENDOTOXIN LETHALITY BY STAPHYLOCOCCAL ENTEROTOXIN.

Authors:  H SUGIYAMA; E M MCKISSIC; M S BERGDOLL; B HELLER
Journal:  J Infect Dis       Date:  1964-04       Impact factor: 5.226

3.  Pyrogenic specificity of streptococcal exotoxins, staphylococcal enterotoxin, and gram-negative endotoxin.

Authors:  K W Brunson; D W Watson
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441

4.  The mitogenic effects of endotoxin and staphylococcal enterotoxin B on mouse spleen cells and human peripheral lymphocytes.

Authors:  D L Peavy; W H Adler; R T Smith
Journal:  J Immunol       Date:  1970-12       Impact factor: 5.422

5.  Purification of staphylococcal enterotoxin B.

Authors:  E J Schantz; W G Roessler; J Wagman; L Spero; D A Dunnery; M S Bergdoll
Journal:  Biochemistry       Date:  1965-06       Impact factor: 3.162

6.  Concomitant loss of conformation and superantigenic activity of staphylococcal enterotoxin B deletion mutant proteins.

Authors:  B Metzroth; T Marx; M Linnig; B Fleischer
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

7.  Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1.

Authors:  M L Hoffmann; L M Jablonski; K K Crum; S P Hackett; Y I Chi; C V Stauffacher; D L Stevens; G A Bohach
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock.

Authors:  A G Bean; R A Freiberg; S Andrade; S Menon; A Zlotnik
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Method for simultaneous isolation and quantitation of platelet activating factor and multiple arachidonate metabolites from small samples: analysis of effects of Staphylococcus aureus enterotoxin B in mice.

Authors:  T Boyle; V Lancaster; R Hunt; P Gemski; M Jett
Journal:  Anal Biochem       Date:  1994-02-01       Impact factor: 3.365

10.  Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins.

Authors:  T O Harris; D Grossman; J W Kappler; P Marrack; R R Rich; M J Betley
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more
  9 in total

1.  Inhibition of bacterial superantigens by peptides and antibodies.

Authors:  K Visvanathan; A Charles; J Bannan; P Pugach; K Kashfi; J B Zabriskie
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Identification of a transcytosis epitope on staphylococcal enterotoxins.

Authors:  Jeffrey W Shupp; Marti Jett; Carol H Pontzer
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

Review 3.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

4.  Biological activities of staphylococcal enterotoxin type A mutants with N-terminal substitutions.

Authors:  T O Harris; M J Betley
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

5.  Production of tumor necrosis factor alpha in human T lymphocytes by staphylococcal enterotoxin B correlates with toxin-induced proliferation and is regulated through protein kinase C.

Authors:  Z Yan; D C Yang; R Neill; M Jett
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

Review 6.  Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome.

Authors:  Amanda J Brosnahan; Patrick M Schlievert
Journal:  FEBS J       Date:  2011-05-19       Impact factor: 5.542

7.  Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody.

Authors:  L T Pang; W W Kum; A W Chow
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

8.  Mitogenic activities of amino acid substitution mutants of staphylococcal enterotoxin B in human and mouse lymphocyte cultures.

Authors:  R J Neill; M Jett; R Crane; J Wootres; C Welch; D Hoover; P Gemski
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

9.  Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model.

Authors:  B G Stiles; T Krakauer; P F Bonventre
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.